HFRG
LNAI

Houlihan Financial Resource Group’s Lunai Bioworks LNAI Stock Holding History

Houlihan Financial Resource Group’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,519
Closed -$193K – 146
2023
Q2 		$193K Buy
+2,519
New +$193K 0.01% 128

Other funds holding LNAI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Houlihan Financial Resource Group's LNAI Position: Q3 2023 in Review

Houlihan Financial Resource Group sold out of Lunai Bioworks (LNAI) in Q3 2023, closing a stake of 2,519 shares — an estimated $193K sold.

Houlihan Financial Resource Group first reported a position in LNAI in Q2 2023 and held it in 1 quarter. The position peaked at $193K in Q2 2023. 21 funds tracked by Wall St. Rank hold LNAI as of Q3 2023.

  • Houlihan Financial Resource Group reported no remaining Lunai Bioworks position as of Q3 2023 after selling out during the quarter.
  • Houlihan Financial Resource Group sold 2,519 Lunai Bioworks shares in Q3 2023, an estimated $193K.
  • Houlihan Financial Resource Group first reported a position in Lunai Bioworks in Q2 2023 and held it in 1 quarter.
  • Houlihan Financial Resource Group's Lunai Bioworks position peaked at $193K in Q2 2023.
  • 21 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2023.

Based on Houlihan Financial Resource Group's 13F filing for Q3 2023, filed 9 Nov 2023.